BioSpace News Archive

Boehringer Ingelheim Pharmaceuticals Inc. welcomes the updated 2023 Global Initiative for Chronic Obstructive Lung Disease Report recommending long‐acting muscarinic antagonist plus long‐acting beta‐agonist as the optimal first-line treatment option for most patients with COPD, regardless of exacerbation risk.

Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced plans to explore strategic alternatives to maximize the shareholder value potential of its SofPulse ® Pulsed Electro Magnetic Frequency (PEMF) proprietary assets.

Beren Therapeutics, P.B.C. announced that its novel lead asset, BRN-002, was awarded an Innovation Passport under the United Kingdom’s Innovative Licensing and Access Pathway, for the reversal of atherosclerosis in patients with Homozygous Familial Hypercholesterolemia.

ValnevaSE, a specialty vaccine company, announced the appointment of Dipal Patel as Chief Commercial Officer and Management Board member.

VISEN Pharmaceuticals released for the first time detailed clinical data from its pivotal Phase 3 study of lonapegsomatropin, a long-acting prodrug of unmodified somatropin being investigated as a once-weekly injection in children with growth hormone deficiency in China.

BioArctic AB announced that the company is expanding its alpha-synuclein project portfolio.

Evaxion Biotech A/S today announced promising clinical data from the Phase 1/2a first-in-human study of its DNA-based cancer immunotherapy, EVX-02.

Immatics N.V. provided a business update and reported financial results for the quarter ended September 30, 2022.

Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the full commercial launch of its new Imprint™ knee system.

Inspirna, Inc. announced today that Chief Executive Officer Masoud Tavazoie, M.D., Ph.D., and Chief Operating Officer David Darst, MBA, will participate in a fireside chat at the Evercore ISI Annual HealthCONx Conference on November 29, 2022 at 4:45pm ET hosted by Evercore ISI research analyst Umer Raffat.